TBK1 and metabolic disease: TBK1, also known as NF-κB-activating kinase (NAK) or T2K, which is widely expressed in all tissues, has emerged as a prospective therapeutic target, playing increasingly momentous roles in metabolic diseases, autoimmune diseases, and cancer.3